Market Overview:
The global bone tumor ablation devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of bone tumors, technological advancements in bone tumor ablation devices, and rising demand for minimally invasive procedures. Based on type, the global bone tumor ablation devices market is segmented into radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and others. RFA is expected to account for the largest share of the global market in 2018 owing to its high efficacy and safety profile. Based on application, hospitals are expected to account for the largest share of the global market in 2018 followed by ambulatory surgical centers (ASCs) and specialty clinics.
Product Definition:
Bone tumor ablation devices are used to treat bone tumors. They use heat or radiation to kill the tumor cells. This can help to shrink the tumor and improve symptoms.
Radiofrequency Ablation:
Radiofrequency Ablation (RFA) is a minimally invasive surgical procedure used to treat patients suffering from bone metastases. It uses high-intensity focused ultrasound or radiofrequency waves to destroy cancer cells in the vicinity of the tumor, causing them to die without affecting surrounding tissues. RFA has been found useful in treating patients with bone metastases and can be used either as an outpatient procedure or as a daycare surgery depending on patient’s convenience and medical condition.
Microwave Ablation:
The microwave ablation market is expected to witness lucrative growth over the forecast period owing to factors such as increasing geriatric population base, rising prevalence of cancer and cardiovascular diseases along with changing lifestyle habits. Microwave ablation devices are used for the treatment of various target disorders including bone tumor, skin tumors, vascular tumors & cysts and others.
Application Insights:
The hospitals segment dominated the market in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to factors such as a high number of patients with metastatic bone tumors, favorable reimbursement policies, and increasing awareness among healthcare providers regarding this procedure. Radiofrequency ablation is most commonly used for treating bone tumors at hospitals due to availability of advanced equipment and experienced staff.
Specialty clinics are anticipated to witness lucrative growth over the forecast period owing to an increase in demand for minimally invasive procedures that lead towards less postoperative pain & trauma along with faster healing process. Minimally invasive surgeries involve use of devices such as endoscopes for visualization of tumor sites followed by introduction of device into tumor site through small incisions made in skin surface or body wall muscles (abdomen).
Regional Analysis:
North America dominated the global bone tumor ablation devices market in 2017. This can be attributed to the presence of sophisticated healthcare infrastructure, high adoption rate of technologically advanced procedures, and a large number of patients suffering from osteosarcoma & other rare tumors. In addition, increasing government funding for R&D activities pertaining to minimally invasive surgeries is also expected to drive growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare facilities and an increase in medical tourism in this region coupled with rising awareness about advanced treatment options for various cancers & diseases such as osteosarcoma & others are anticipated boost demand for BTA devices used worldwide during 2018-2030 period. Moreover, growing investments by key players on expanding their distribution network will further fuel revenue generation over this eight years time frame as well as beyond 2030 into infinity :-)).
Growth Factors:
- Increasing incidence of bone tumors
- Growing demand for minimally invasive procedures
- Technological advancements in bone tumor ablation devices
- Rising awareness about bone tumor ablation devices
- increasing number of clinical trials for novel bone tumor ablation devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone Tumor Ablation Devices Market Research Report
By Type
Radiofrequency Ablation, Microwave Ablation, Cryoablation, Others
By Application
Hospitals, Ambulatory Surgical Centers, Specialty Clinics
By Companies
Medtronic Plc, Merit Medical Systems Inc, MedWaves Inc, AngioDynamics Inc, Olympus Corporation, Varian Medical Systems, Inc, Mermaid Medical, RF Medical Co., Ltd, Misomix Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Bone Tumor Ablation Devices Market Report Segments:
The global Bone Tumor Ablation Devices market is segmented on the basis of:
Types
Radiofrequency Ablation, Microwave Ablation, Cryoablation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic Plc
- Merit Medical Systems Inc
- MedWaves Inc
- AngioDynamics Inc
- Olympus Corporation
- Varian Medical Systems, Inc
- Mermaid Medical
- RF Medical Co., Ltd
- Misomix Inc
Highlights of The Bone Tumor Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone Tumor Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone tumor ablation devices are medical devices that use heat and radiation to destroy tumors.
Some of the key players operating in the bone tumor ablation devices market are Medtronic Plc, Merit Medical Systems Inc, MedWaves Inc, AngioDynamics Inc, Olympus Corporation, Varian Medical Systems, Inc, Mermaid Medical, RF Medical Co., Ltd, Misomix Inc.
The bone tumor ablation devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bone Tumor Ablation Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bone Tumor Ablation Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bone Tumor Ablation Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bone Tumor Ablation Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bone Tumor Ablation Devices Market Size & Forecast, 2018-2028
4.5.1 Bone Tumor Ablation Devices Market Size and Y-o-Y Growth
4.5.2 Bone Tumor Ablation Devices Market Absolute $ Opportunity
Chapter 5 Global Bone Tumor Ablation Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bone Tumor Ablation Devices Market Size Forecast by Type
5.2.1 Radiofrequency Ablation
5.2.2 Microwave Ablation
5.2.3 Cryoablation
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bone Tumor Ablation Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bone Tumor Ablation Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Specialty Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bone Tumor Ablation Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bone Tumor Ablation Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bone Tumor Ablation Devices Analysis and Forecast
9.1 Introduction
9.2 North America Bone Tumor Ablation Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bone Tumor Ablation Devices Market Size Forecast by Type
9.6.1 Radiofrequency Ablation
9.6.2 Microwave Ablation
9.6.3 Cryoablation
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bone Tumor Ablation Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Specialty Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bone Tumor Ablation Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Bone Tumor Ablation Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bone Tumor Ablation Devices Market Size Forecast by Type
10.6.1 Radiofrequency Ablation
10.6.2 Microwave Ablation
10.6.3 Cryoablation
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bone Tumor Ablation Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Specialty Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bone Tumor Ablation Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bone Tumor Ablation Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bone Tumor Ablation Devices Market Size Forecast by Type
11.6.1 Radiofrequency Ablation
11.6.2 Microwave Ablation
11.6.3 Cryoablation
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bone Tumor Ablation Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Specialty Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bone Tumor Ablation Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Bone Tumor Ablation Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bone Tumor Ablation Devices Market Size Forecast by Type
12.6.1 Radiofrequency Ablation
12.6.2 Microwave Ablation
12.6.3 Cryoablation
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bone Tumor Ablation Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Specialty Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bone Tumor Ablation Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bone Tumor Ablation Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bone Tumor Ablation Devices Market Size Forecast by Type
13.6.1 Radiofrequency Ablation
13.6.2 Microwave Ablation
13.6.3 Cryoablation
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bone Tumor Ablation Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Specialty Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bone Tumor Ablation Devices Market: Competitive Dashboard
14.2 Global Bone Tumor Ablation Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic Plc
14.3.2 Merit Medical Systems Inc
14.3.3 MedWaves Inc
14.3.4 AngioDynamics Inc
14.3.5 Olympus Corporation
14.3.6 Varian Medical Systems, Inc
14.3.7 Mermaid Medical
14.3.8 RF Medical Co., Ltd
14.3.9 Misomix Inc
